Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2025 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results

“Our first quarter delivered meaningful progress across clinical, financial, and strategic initiatives,” said James Nathanielsz, CEO of Propanc.
November 17, 2025 08:30 ET | Source: Azurity Pharmaceuticals

Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity

Woburn, MA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals and Sebela Pharmaceuticals announced today Azurity’s successful acquisition of Sebela’s Bowel Prep Franchise, including two...
November 17, 2025 08:00 ET | Source: Curium

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Curium Biopharma will continue to lead discovery and new product development Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancerCurium...
November 17, 2025 08:00 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of...
November 17, 2025 05:53 ET | Source: Adcytherix

Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse

Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhouse Adcytherix reinforces its Executive Committee with two pivotal appointments: CMO and CFOThe ADCX...
November 17, 2025 01:00 ET | Source: AKAMPION

Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic

Available funding totaling EUR 20 million dedicated to developing novel solid tumor treatments addressing a high unmet medical needSpringboard Health Angels, Pluton Asset Holding AG, Sintra Limited,...
November 13, 2025 16:15 ET | Source: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform...
November 13, 2025 11:00 ET | Source: Persephone Biosciences, Inc.

Persephone Biosciences Announces Topline Results from AMBROSIA Food as Medicine Study with Kroger Health

Persephone Biosciences Announces Topline Results from AMBROSIA Food as Medicine Study with Kroger Health
November 13, 2025 08:45 ET | Source: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Salarius Pharmaceuticals and Decoy Therapeutics complete merger
November 10, 2025 13:26 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting

VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies...